on 23 Aug 2022
Last Applicant/ Owned by
Gangnam-gu Seoul
KR
Serial Number
79302745 filed on 01st Dec 2020
Registration Number
6822946 registered on 23rd Aug 2022
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical agents affecting sensory organs; pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the treatment of musculo-skeletal disorders; pharmaceutical prepa Read More
Pharmaceutical agents affecting sensory organs; pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the treatment of musculo-skeletal disorders; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; pharmaceutical preparations for peripheral nervous system; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical products for the treatment of viral diseases; pharmaceuticals for the treatment of erectile dysfunction; vaccines; anti-inflammatory preparations; medicines for intestinal disorders; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; ophthalmic preparations; biological preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical agents for epidermis; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; enzymes for medical purposes; diagnostic preparations for medical or veterinary purposes; immunoassay reagents for medical use; medical reagents for testing genetic identity for medical purposes; pharmaceutical preparations for neurological disease; pharmaceutical preparations for inflammatory diseases; pharmaceutical preparations for ocular and intraocular surgery; pharmaceutical preparations for rare autoimmune diseases in the nature of autoimmune lymphoproliferative syndrome, lupus, and multiple sclerosis; pharmaceutical products for the treatment of rare autoimmune diseases and disorders; pharmaceutical products for the prevention and treatment of rare genetic diseases affecting red blood cells; medicated ointments for treating dermatological conditions; antibiotic ointments; mentholated ointment for medical use; anti-inflammatory ointments; chemical reagents for purposes of medical diagnosis; diagnostic preparations for diagnosing inflammatory diseases; diagnostic radiopharmaceutical preparations; pharmaceutical and biological preparations for use in diagnosis, namely, for use as ultrasound and X-ray contrast reagents; human vaccine preparations; pharmaceutical preparations acting on the central nervous system; preparations for the treatment of asthma; medicines for dental purposes; dermatological pharmaceutical products; pharmaceutical preparations for skin care; pharmaceutical preparations for treating skin disorders; antibiotics; anti-cancer preparations; tumor suppressing agents; pharmaceutical products for treating respiratory diseases
No 79302745
No Service/Collective Mark
No 4897.0002
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
01st Dec 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
01st Dec 2022 | FINAL DISPOSITION PROCESSED |
23rd Nov 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
23rd Aug 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
23rd Aug 2022 | REGISTERED-PRINCIPAL REGISTER |
12th Jul 2022 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
22nd Jun 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
22nd Jun 2022 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
07th Jun 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
07th Jun 2022 | PUBLISHED FOR OPPOSITION |